Table 4 Paired t-contrasts comparing OT administered with the nebulizer to placebo/saline.

From: Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans

Cluster description

Hemisphere

K

Pfwe

Peak coordinates

Description

x

y

z

Nebulizer < placebo (15–23 min)

 Cluster 1: caudate, putamen, pallidum*

Left

434

0.037

−18

0

20

Left caudate

−12

8

8

−6

2

16

Nebulizer > placebo (24–32 min)

 Cluster 2: superior, middle and inferior occipital gyrus, calcarine sulcus, cuneus

Bilateral

1154

<0.001

52

−74

−8

Right inferior occipital gyrus

38

−92

−2

40

−88

−14

 Cluster 3: cerebellum*

Right

457

0.033

26

−72

−28

Right cerebellum

12

−82

−28

4

−86

−38

Nebulizer > placebo (75–83 min)

 Cluster 4: postcentral gyrus, superior, middle and inferior occipital gyrus, superior parietal gyrus, inferior and middle temporal gyrus, precuneus, calcarine sulcus, cuneus

Right

2546

<0.001

56

−66

−16

Right inferior temporal gyrus

28

−54

72

Right Superior Parietal Lobule

48

−78

−16

Right inferior occipital gyrus

Nebulizer < placebo (75–83 min)

 Cluster 5: caudate, putamen, pallidum, thalamus, amygdala, hippocampus, olfactory region, insula

Left

1229

<0.001

−14

0

18

Left caudate

−12

−14

−10

Left ventral diencephalon

−6

−6

4

Left thalamus

  1. We compared CBF maps following OT administered with the nebulizer to placebo/saline using paired t-contrasts at each time-interval (to capture the direction of potential rCBF changes), controlling for global CBF as a nuisance variable. We conducted cluster-level inference, reporting clusters significant at p < 0.05 FWE-corrected (cluster-forming threshold: p < 0.005, uncorrected). Clusters that do not survive correction for multiple testing following adjustment of the P-value using Bonferroni correction for the 24 paired-t-tests performed are denoted by an asterisk (*) (Padjusted = 0.05/24 = 0.002).